Breast cancer test extended

Lifeline Biotechnologies, Inc. and its affiliate, Cyrcadia Health has extended its clinical trial for early breast cancer detection to The Stefanie Spielman Comprehensive Breast Center at The Ohio State University.

Comments

Use the comment form below to begin a discussion about this content.

Sign in to comment